Gerresheimer AG GRRMF
37.47 USD 0.00 (+0.00%)
At closeNov 9, 2026, 4:00 PM EST
37.39 Day range 37.47
19.17 52-week range 51.41
- YTD
- -27.12%
- 1 year
- -27.12%
News
seekingalpha.com Gerresheimer AG (GRRMY) Q3 2026 Earnings Call Transcript Gerresheimer AG (GRRMY) Q3 2026 Earnings Call Transcript
marketbeat.com Gerresheimer Q3 Earnings Call Highlights Gerresheimer ETR: GXI reported preliminary third-quarter 2026 revenue growth across all three business segments, while adjusted EBITDA was broadly stable as inventory reductions weighed on…
seekingalpha.com Gerresheimer AG (GRRMY) Q2 2026 Earnings Call Transcript Gerresheimer AG (GRRMY) Q2 2026 Earnings Call Transcript
marketbeat.com What Gerresheimer (GXI) Said on Its Q2 Earnings Call Gerresheimer ETR: GXI reported a sequential improvement in preliminary second-quarter 2026 results, with adjusted EBITDA rising more than 50% from the first quarter as operational initiatives began…
reuters.com Gerresheimer reports lower half-year core profit Drug-packaging maker Gerresheimer reported a lower core profit for the first half of 2026 on Wednesday, as weakness in its Moulded Glass business and lower demand for injection vials weighed…
seekingalpha.com Gerresheimer AG (GRRMY) Q1 2026 Earnings Call Transcript Gerresheimer AG (GRRMY) Q1 2026 Earnings Call Transcript
marketbeat.com Gerresheimer Q1 Earnings Call Highlights Gerresheimer ETR: GXI reported preliminary first-quarter 2026 results that showed modest revenue growth but lower earnings as the packaging and drug-delivery company prioritized cash preservation,…
reuters.com Germany's Gerresheimer to sell two units to Apax for $1.71 billion including debt German drugs packaging firm Gerresheimer said on Wednesday it was selling two of its packaging units to private equity group Apax Funds for €1.5 billion ($1.71 billion) including debt.
marketbeat.com Gerresheimer Q4 Earnings Call Highlights Gerresheimer ETR: GXI said it has completed a broad review of compliance and accounting matters, published its audited 2025 annual report and is now focused on selling Centor, refinancing debt and…
reuters.com Gerresheimer rejects takeover bid from US packing firm Silgan, say sources German medical packaging maker Gerresheimer has rejected a takeover bid from its U.S. rival Silgan , three sources familiar with the situation told Reuters.
reuters.com Gerresheimer delays 2025 results release to June, stock to be removed from SDAX Gerresheimer on Tuesday again deferred the release of 2025 financial statements to June, citing a probe into its business deals, a delay that is now set to cost the German medical products maker…
seekingalpha.com Diamond Hill International Strategy Q4 2025 Portfolio Review Diamond Hill International Strategy returned 3.87% (net of fees) and the MSCI ACWI ex USA Index returned 5.05%. Sumitomo Densetsu, a Japanese electrical contractor, benefited from a takeover bid by…
reuters.com Gerresheimer appoints Uwe Röhrhoff as new interim CEO Medical equipment maker Gerresheimer said on Tuesday it had appointed Uwe Röhrhoff as interim CEO, effective November 1, 2025. He succeeds Dietmar Siemssen, who will step down as CEO by mutual…
reuters.com Gerresheimer finds 2024 revenue-recognition issues after external probe Medical equipment maker Gerresheimer said it has obtained the initial findings from an investigation by an external law firm into the recognition of revenue and profit from bill-and-hold agreements…
seekingalpha.com Gerresheimer AG (GRRMY) Q3 2025 Earnings Call Transcript Gerresheimer AG (OTCPK:GRRMY) Q3 2025 Earnings Call October 9, 2025 2:30 AM EDT Company Participants Guido Pickert - Head of Investor Relations Dietmar Siemssen - CEO, Chairman of the Management…
reuters.com Gerresheimer's shares fall 11% after another outlook cut Shares in Gerresheimer fell 11% on Thursday, a day after the German packaging and medical equipment maker cut its 2025 guidance for the third time this year.
reuters.com Gerresheimer cuts 2025 outlook again as Q3 disappoints German packaging and medical equipment maker Gerresheimer cut its 2025 guidance again on Wednesday, now expecting organic revenues to decline between 2-4% as third quarter results fell below…
reuters.com Gerresheimer shares tank as financial regulator suspects accounting flaws Shares in medical equipment maker Gerresheimer plunged as much as 38% on Wednesday after Germany's financial regulator said it was investigating suspected accounting rule violations.
reuters.com Activist investor wants review at Gerresheimer after taking stake Active Ownership, a major shareholder in Gerresheimer , said on Thursday it saw major potential for value creation at the German packaging and medical equipment specialist and called for a strategic…benzinga.com Stocks That Hit 52-Week Highs On Wednesday
